Skip To Main Content
Kenneth Anderson on Muck Rack

Kenneth Anderson

As seen in: Medium, Nature, Wiley Online Library, Teachers College Record, Emergency Medicine Journal, MDPI, Brookings Institution, BioRxiv, STAT, Healio and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kenneth

Contact Kenneth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Implications of the Results From CARTITUDE-1 for Future Research and Care in Multiple Myeloma

|
By Kenneth Anderson
| The ASCO Post Verified
The results from the CARTITUDE-1 study showed the remarkable efficacy of ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy, when used in patients with relapsed or refractory multiple myeloma after four or more prior lines of therapies.
Open in Who Shared Issue with article?

Broiler Breeders Fed Diets Supplemented with Conventional or Lipid Matrix Microencapsulated Trace Minerals at Standard or High Levels: Part I. Influence on Production, Skeletal Integrity, and Intestinal Histomorphology of Broiler Breeders

|
By Ramon D. Malheiros, Kenneth Anderson, Peter Ferket, Dimitri M. Malheiros
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Clinical Trial Endpoints for Timely Drug Development

|
By Kenneth Anderson
| Cancer Today Verified
MANY PATIENTS WITH CANCER are living long and fulfilling lives thanks to advances in treatments. Some cancer types have a number of therapeutic options that patients can choose when one treatment fails. These incredible successes, built upon decades of basic and clinical research, are worthy of celebration, but they pose increasing challenges for developing new therapies.
Open in Who Shared Issue with article?
See all 71 licensed articles (76 Total)